Bi W, Rao J Y, Hemstreet G P, Fang P, Asal N R, Zang M, Min K W, Ma Z, Lee E, Li G
Department of Toxicology and Epidemiology, Chinese Academy of Preventive Medicine, Beijing.
J Occup Med. 1993 Jan;35(1):20-7.
Modern molecular and cellular biology have provided powerful new approaches to study cancer in the research laboratory, but these techniques have not been used extensively in field studies or in screening of high-risk occupational cohorts. The primary objective of this study was to demonstrate the use of cellular and molecular methods in combination with medical and epidemiologic methods to identify cancer cases, risk factors, and markers in a previously identified and defined cohort of Chinese workers exposed to benzidine. The screening of exposed workers included occupational, medical, and smoking histories to identify exogenous risk factors, a limited physical examination, Papanicolaou (PAP) urinary cytology, measurement of urine pH, quantitative fluorescence image analysis (QFIA) cytology to detect DNA hyperploidy, and quantitative fluorescence to detect expression of a low-grade bladder tumor-associated antigen (p300) by exfoliated urothelial cells and elevated expression of the neu oncogene product (p185). Detailed analysis of the accuracy of epidemiologic data and the adequacy of samples and accuracy of molecular techniques was carried out. Three groups were included in this study: group 1 included 23 bladder cancer cases who had previously been exposed to benzidine and served as two surrogates for late-emerging disease; group 2 consisted of 20 subjects with previous exposure history but not previously diagnosed with bladder cancer; and group 0 was the nonexposure and nonbladder cancer controls. The results showed that accurate questionnaire data and urine samples can be obtained at remote sites. Among the 20 group 2 subjects, two displayed abnormal findings by both QFIA cytology and p300 expression and were later confirmed to have bladder cancer.(ABSTRACT TRUNCATED AT 250 WORDS)
现代分子与细胞生物学为在研究实验室中研究癌症提供了强大的新方法,但这些技术尚未在现场研究或高危职业人群筛查中广泛应用。本研究的主要目的是证明将细胞和分子方法与医学及流行病学方法相结合,以在先前确定和界定的接触联苯胺的中国工人队列中识别癌症病例、风险因素和标志物。对接触工人的筛查包括职业、医疗和吸烟史以识别外源性风险因素、有限的体格检查、巴氏(PAP)尿细胞学检查、尿液pH值测量、用于检测DNA超倍体的定量荧光图像分析(QFIA)细胞学检查,以及用于检测脱落尿路上皮细胞中低级别膀胱肿瘤相关抗原(p300)表达和神经癌基因产物(p185)表达升高的定量荧光检查。对流行病学数据的准确性、样本的充分性以及分子技术的准确性进行了详细分析。本研究包括三组:第1组包括23例先前接触过联苯胺的膀胱癌病例,作为晚期发病的两个替代病例;第2组由20名有既往接触史但先前未被诊断出患有膀胱癌的受试者组成;第0组为未接触且无膀胱癌的对照组。结果表明,可在偏远地点获得准确的问卷数据和尿液样本。在第2组的20名受试者中,有两名在QFIA细胞学检查和p300表达方面均显示异常结果,后来被确诊患有膀胱癌。(摘要截短为250字)